4,097 Shares in Teleflex Incorporated $TFX Bought by Hunter Perkins Capital Management LLC

by · The Cerbat Gem

Hunter Perkins Capital Management LLC bought a new stake in Teleflex Incorporated (NYSE:TFX – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 4,097 shares of the medical technology company’s stock, valued at approximately $501,000.

Other large investors have also made changes to their positions in the company. Cooke & Bieler LP increased its position in shares of Teleflex by 14.0% during the 2nd quarter. Cooke & Bieler LP now owns 1,205,964 shares of the medical technology company’s stock valued at $142,738,000 after purchasing an additional 148,436 shares during the last quarter. Qube Research & Technologies Ltd boosted its holdings in shares of Teleflex by 100.1% in the second quarter. Qube Research & Technologies Ltd now owns 606,804 shares of the medical technology company’s stock worth $71,821,000 after buying an additional 303,521 shares during the last quarter. Norges Bank bought a new stake in Teleflex during the second quarter valued at approximately $65,826,000. AQR Capital Management LLC increased its holdings in Teleflex by 39.9% during the second quarter. AQR Capital Management LLC now owns 409,320 shares of the medical technology company’s stock valued at $48,447,000 after buying an additional 116,797 shares during the last quarter. Finally, Millennium Management LLC raised its position in Teleflex by 57.8% in the first quarter. Millennium Management LLC now owns 394,633 shares of the medical technology company’s stock worth $54,534,000 after acquiring an additional 144,531 shares during the period. 95.62% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on TFX. Wall Street Zen downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a research report on Saturday, November 15th. Royal Bank Of Canada reaffirmed a “sector perform” rating and set a $135.00 price objective on shares of Teleflex in a research report on Wednesday, December 17th. Zacks Research lowered shares of Teleflex from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 30th. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a report on Tuesday, December 9th. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Teleflex in a research note on Monday. One analyst has rated the stock with a Buy rating, nine have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Reduce” and an average target price of $142.43.

Check Out Our Latest Stock Report on Teleflex

Teleflex Stock Performance

TFX opened at $122.33 on Thursday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.53 and a current ratio of 2.57. The stock has a market capitalization of $5.41 billion, a price-to-earnings ratio of -16.64, a PEG ratio of 1.46 and a beta of 0.95. The company has a fifty day moving average of $120.22 and a 200 day moving average of $121.04. Teleflex Incorporated has a fifty-two week low of $102.58 and a fifty-two week high of $185.94.

Teleflex (NYSE:TFX – Get Free Report) last released its quarterly earnings data on Thursday, November 6th. The medical technology company reported $3.67 EPS for the quarter, beating the consensus estimate of $3.38 by $0.29. The business had revenue of $892.90 million during the quarter, compared to the consensus estimate of $892.79 million. Teleflex had a negative net margin of 10.28% and a positive return on equity of 15.64%. The business’s revenue was up 19.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $3.49 EPS. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. As a group, sell-side analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, December 15th. Stockholders of record on Friday, November 14th were issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 1.1%. The ex-dividend date of this dividend was Friday, November 14th. Teleflex’s dividend payout ratio is -18.50%.

About Teleflex

(Free Report)

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

Further Reading

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Free Report).